The American Society For Microbiology Honors Manuela Raffatellu
Main Category: Infectious Diseases / Bacteria / VirusesAlso Included In: GastroIntestinal / Gastroenterology
Article Date: 12 Aug 2010 - 4:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
Manuela Raffatellu, M.D., Assistant Professor, Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, has been chosen by the American Society for Microbiology (ASM) to receive a 2010 ICAAC Young Investigator Award. Sponsored by the ASM, this award recognizes an early career scientist for research excellence in microbiology and infectious diseases.
Dr. Raffatellu earned her M.D. at the University of Sassari, Italy, and completed her postdoctoral work at Texas A&M University and the University of California, Davis.
Early in her post-doctoral studies, Dr. Raffatellu was intrigued by the clinical observation that the human pathogen Salmonella typhi does not trigger an inflammatory response in the gut. Her subsequent work contributed to the identification of the Vi capsular antigen as a novel virulence factor promoting immune evasion by S. typhi. More recently, Dr. Raffatellu's research has been focused on the gut pathogen Salmonella typhimurium, with the goal of elucidating its interaction with both immunocompetent and immunocompromised hosts. Dr. Raffatellu became interested in understanding which components of the gut inflammatory response prevent S. typhimurium from systemic spreading by containing the infection to the mucosa. Her work has identified a novel role for early T cell responses and the cytokine IL-17 in preventing S. typhimurium dissemination from the gut, thus benefiting the host. Dr. Raffatellu subsequently began studying the mechanisms by which S. typhimurium thrives in the inflamed gut, and currently continues to work on the mucosal response to Salmonella.
The ICAAC Young Investigator Award will be presented during ASM's 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 12-15, 2010 in Boston, MA.
Source:
Garth Hogan
American Society for Microbiology
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/197586.php>
APA
http://www.medicalnewstoday.com/releases/197586.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



